<DOC>
<DOCNO>EP-0639077</DOCNO> 
<TEXT>
<INVENTION-TITLE>
DRUG FOR INCREASING THE LEVEL OF TESTOSTERONE IN THE BODY
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3157	A61P524	A61P500	C07J100	A61K4500	A61K4500	A61K920	A61P4300	A61P4300	A61K920	A61K3157	C07J100	A61K315685	A61K31568	A61K31565	A61K31565	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61P	A61P	C07J	A61K	A61K	A61K	A61P	A61P	A61K	A61K	C07J	A61K	A61K	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61P5	A61P5	C07J1	A61K45	A61K45	A61K9	A61P43	A61P43	A61K9	A61K31	C07J1	A61K31	A61K31	A61K31	A61K31	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
ARROWDEAN LTD
</APPLICANT-NAME>
<APPLICANT-NAME>
ARROWDEAN LTD.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
HAECKER RUEDIGER
</INVENTOR-NAME>
<INVENTOR-NAME>
MATTERN CLAUDIA
</INVENTOR-NAME>
<INVENTOR-NAME>
HAECKER, RUEDIGER
</INVENTOR-NAME>
<INVENTOR-NAME>
MATTERN, CLAUDIA
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Use of at least one of the following compounds: 
androstenedione, progesterone or 17-Î±-hydroxyprogesterone 

for producing a drug in a form of 
administration for nasal application, for increasing 

the testosterone level in man. 
</CLAIMS>
</TEXT>
</DOC>
